ArticleJournal of animal science2025
The effects of a plant-based and a plant- and marine-based n-3 oil supplement on behavioral reactivity, heart rate variability, and plasma fatty acid profile in young healthy horses.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behavioral reactivity in horses poses a welfare and safety risk to both the horse and the handler, however, beneficial effects have been observed when dietary fat is increased in replacement of sugar. Supplementation with the fatty acids (FA) eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) appear to improve negative behaviors in rodents and humans, but the effect of α-linolenic acid (ALA), EPA, and DHA, specifically, on reactivity in horses is unknown. The objective of this study was to evaluate the effects of camelina oil (CAM; ALA-enriched) and a mix of camelina and algal oil (ALG; ALA-, EPA-, and DHA-enriched) both fed at a dose of 0.37 g oil/kg body weight on plasma FA, behavior, and heart rate variability (HRV) in young horses compared to a negative control (CON). Thirty-four client-owned horses aged 7 mo to 6 yr were enrolled. Horses were assigned to either CAM, ALG, or CON and underwent a novel object test (NOT) before and after a 6-wk supplementation period. Prior to each NOT, blood was collected for evaluation of plasma FA profile (n = 28). During the NOT, behavior was recorded using a predetermined ethogram and assessed in BORIS software by 2 raters (n = 29). Electrocardiogram (ECG) data was collected at baseline, during the NOT, and after the NOT (recovery). The ECG data was analyzed in Kubios software for determination of heart rate (HR) and several HRV parameters (n = 24). The treatment oils were treated as fixed effects, baseline measurements as covariates, and location as a random effect. Plasma DHA (P < 0.01) was greater and n-6:n-3 ratio (P < 0.01) was reduced in ALG than in CAM and CON, while ALA and EPA were similar among treatments (P > 0.05). When treatments were pooled, the maximum HR (P < 0.01) and the low frequency to high frequency ratio HRV parameter (P < 0.01) were greater during the NOT compared to baseline and recovery. Bucking (P = 0.03) and backing (P = 0.02) behaviors were reduced in the CAM group compared to the CON group, but neither group differed from ALG. All other behaviors, HR, and HRV parameters were similar among treatments (P > 0.05). Our results suggest that the NOT was successful in creating acute stress, however, feeding either CAM or ALG at this dose did not reduce reactivity in this cohort of horses. Further research is needed to understand the effects of specific FA, if any, on behavior and HRV in more specific populations of horses and specifically those deemed highly reactive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.